Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
5 hedge funds and large institutions have $7.87M invested in Plus Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
56% less capital invested
Capital invested by funds: $18M → $7.87M (-$10.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $11K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$4.18M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.79M |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$597K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$597K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cambridge Associates
Boston,
Massachusetts
|
-$852K |
| 2 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
-$135K |
| 3 |
Goldman Sachs
New York
|
-$28K |
| 4 |
Bank of New York Mellon
New York
|
-$23K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJFSA
51
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$4K | – | – |
|
|
RAM
52
Redmond Asset Management
Henrico,
Virginia
| – | -$135K | – | – |
|
|
SFA
53
Sequoia Financial Advisors
Akron,
Ohio
| – | -$5K | – | – |
|
|
SI
54
SII Investments
Appleton,
Wisconsin
| – | -$9K | – | – |
|
55
State Street
Boston,
Massachusetts
| – | -$7K | – | – |
|
|
VKH
56
Virtu KCG Holdings
New York
| – | -$22K | – | – |
|
PSTV Hedge Fund Activity: Q2 2016 in Review
5 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2016, worth a combined $7.87M — down 56% from $18M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PSTV positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $4.18M. The largest seller was Cambridge Associates, cutting an estimated $852K.
- 5 institutional investors held Plus Therapeutics (PSTV) as of Q2 2016, up from 4 in Q1 2016.
- Funds reported $7.87M of Plus Therapeutics stock for Q2 2016, down 56% quarter-over-quarter.
- 1 fund opened new Plus Therapeutics positions in Q2 2016 and 0 closed out, a net change of +1 holder.
- The largest Plus Therapeutics buyer in Q2 2016 was Sabby Management, an estimated $4.18M added.
- The largest Plus Therapeutics seller in Q2 2016 was Cambridge Associates, an estimated $852K sold.
Based on aggregated 13F filings for Q2 2016.